2011 Scrip 100: Back to the 70s?
This article was originally published in Scrip
Executive Summary
Headline Indian M&A has sparked a fierce debate in policy circles, with many fearing the impact of multinational company dominance on drug prices and access to essential medicines, explains Anju Ghangurde.